Literature DB >> 24478492

Pathogenicity and phenotypic characterization of enterotoxigenic Escherichia coli isolates from a birth cohort of children in rural Egypt.

Adel Mansour1, Hind I Shaheen, Mohamed Amine, Khaled Hassan, John W Sanders, Mark S Riddle, Adam W Armstrong, Ann-Mari Svennerholm, Peter J Sebeny, John D Klena, Sylvia Y N Young, Robert W Frenck.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) has consistently been the predominant bacterial cause of diarrhea in many birth cohort- and hospital-based studies conducted in Egypt. We evaluated the pathogenicity of ETEC isolates in a birth cohort of children living in a rural community in Egypt. Between 2004 and 2007, we enrolled and followed 348 children starting at birth until their second year of life. A stool sample and two rectal swabs were collected from children during twice-weekly visits when they presented with diarrhea and were collected every 2 weeks if no diarrhea was reported. From routine stool cultures, five E. coli-like colonies were screened for ETEC enterotoxins using a GM1 enzyme-linked immunosorbent assay (ELISA). The isolates were screened against a panel of 12 colonization factor antigens (CFAs) by a dot blot assay. A nested case-control study evaluated the association between initial or repeat excretion of ETEC and the occurrences of diarrhea. The pathogenicity of ETEC was estimated in symptomatic children compared to that in asymptomatic controls. ETEC was significantly associated with diarrhea (crude odds ratio, 1.37; 95% confidence interval [CI], 1.24 to 1.52). The distribution of ETEC enterotoxins varied between the symptomatic children (44.2% heat-labile toxin [LT], 38.5% heat-stable toxin [ST], and 17.3% LT/ST) and asymptomatic children (55.5% LT, 34.6% ST, and 9.9% LT/ST) (P < 0.001). The CFAs CFA/I (n = 61), CS3 (n = 8), CS1 plus CS3 (n = 24), CS2 plus CS3 (n = 18), CS6 (n = 45), CS5 plus CS6 (n = 11), CS7 (n = 25), and CS14 (n = 32) were frequently detected in symptomatic children, while CS6 (n = 66), CS12 (n = 51), CFA/I (n = 43), and CS14 (n = 20) were detected at higher frequencies among asymptomatic children. While all toxin phenotypes were associated with diarrheal disease after the initial exposure, only ST and LT/ST-expressing ETEC isolates (P < 0.0001) were associated with disease in repeat infections. The role of enterotoxins and pathogenicity during repeat ETEC infections appears to be variable and dependent on the coexpression of specific CFAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24478492      PMCID: PMC3911313          DOI: 10.1128/JCM.01639-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Enteric pathogens associated with diarrhea in children in Fayoum, Egypt.

Authors:  Hanon El-Mohamady; Ibrahim A Abdel-Messih; Fouad G Youssef; Mohamad Said; Hossaini Farag; Hind I Shaheen; David M Rockabrand; Stephen B Luby; Rana Hajjeh; John W Sanders; Marshall R Monteville; John D Klena; Robert W Frenck
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-03       Impact factor: 2.803

2.  Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-03-17

3.  Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review.

Authors:  Mark S Riddle; John W Sanders; Shannon D Putnam; David R Tribble
Journal:  Am J Trop Med Hyg       Date:  2006-05       Impact factor: 2.345

4.  Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut.

Authors:  James P Nataro; Volker Mai; Judith Johnson; William C Blackwelder; Robert Heimer; Shirley Tirrell; Stephen C Edberg; Christopher R Braden; J Glenn Morris; Jon Mark Hirshon
Journal:  Clin Infect Dis       Date:  2006-07-11       Impact factor: 9.079

5.  Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau.

Authors:  Hans Steinsland; Palle Valentiner-Branth; Michael Perch; Francisco Dias; Thea K Fischer; Peter Aaby; Kåre Mølbak; Halvor Sommerfelt
Journal:  J Infect Dis       Date:  2002-11-18       Impact factor: 5.226

Review 6.  A review of vaccine research and development: human enteric infections.

Authors:  Marc P Girard; Duncan Steele; Claire-Lise Chaignat; Marie Paule Kieny
Journal:  Vaccine       Date:  2005-10-21       Impact factor: 3.641

7.  Comparative analyses of phenotypic and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization factors.

Authors:  A Sjöling; G Wiklund; S J Savarino; D I Cohen; A-M Svennerholm
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

8.  Enterotoxigenic Escherichia coli and Vibrio cholerae diarrhea, Bangladesh, 2004.

Authors:  Firdausi Qadri; Ashraful I Khan; Abu Syed G Faruque; Yasmin Ara Begum; Fahima Chowdhury; Gopinath B Nair; Mohammed A Salam; David A Sack; Ann-Mari Svennerholm
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

9.  Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh.

Authors:  F Qadri; S K Das; A S Faruque; G J Fuchs; M J Albert; R B Sack; A M Svennerholm
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

10.  Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh.

Authors:  Firdausi Qadri; Amit Saha; Tanvir Ahmed; Abdullah Al Tarique; Yasmin Ara Begum; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

View more
  8 in total

Review 1.  A tale of two bacterial enteropathogens and one multivalent vaccine.

Authors:  Eileen M Barry; Myron M Levine
Journal:  Cell Microbiol       Date:  2019-07-10       Impact factor: 3.715

2.  Diarrhea burden due to natural infection with enterotoxigenic Escherichia coli in a birth cohort in a rural Egyptian community.

Authors:  A Mansour; H I Shaheen; M Amine; K Hassan; J W Sanders; M S Riddle; A W Armstrong; A M Svennerholm; P J Sebeny; J D Klena; S Y N Young; R W Frenck
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

3.  Coinfection with Enteric Pathogens in East African Children with Acute Gastroenteritis-Associations and Interpretations.

Authors:  Maria Andersson; Jean-Claude Kabayiza; Kristina Elfving; Staffan Nilsson; Mwinyi I Msellem; Andreas Mårtensson; Anders Björkman; Tomas Bergström; Magnus Lindh
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

4.  Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala.

Authors:  O R Torres; W González; O Lemus; R A Pratdesaba; J A Matute; G Wiklund; D A Sack; A L Bourgeois; A-M Svennerholm
Journal:  Epidemiol Infect       Date:  2014-09-19       Impact factor: 2.451

5.  In Situ Analyses Directly in Diarrheal Stool Reveal Large Variations in Bacterial Load and Active Toxin Expression of Enterotoxigenic Escherichiacoli and Vibrio cholerae.

Authors:  Yasmin Ara Begum; Hanna A Rydberg; Kaisa Thorell; Young-Keun Kwak; Lei Sun; Enrique Joffré; Firdausi Qadri; Åsa Sjöling
Journal:  mSphere       Date:  2018-01-24       Impact factor: 4.389

Review 6.  A roadmap for enterotoxigenic Escherichia coli vaccine development based on volunteer challenge studies.

Authors:  Myron M Levine; Eileen M Barry; Wilbur H Chen
Journal:  Hum Vaccin Immunother       Date:  2019-03-20       Impact factor: 3.452

7.  The LT1 and LT2 variants of the enterotoxigenic Escherichia coli (ETEC) heat-labile toxin (LT) are associated with major ETEC lineages.

Authors:  Enrique Joffré; Åsa Sjöling
Journal:  Gut Microbes       Date:  2016

8.  Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS).

Authors:  Roberto M Vidal; Khitam Muhsen; Sharon M Tennant; Ann-Mari Svennerholm; Samba O Sow; Dipika Sur; Anita K M Zaidi; Abu S G Faruque; Debasish Saha; Richard Adegbola; M Jahangir Hossain; Pedro L Alonso; Robert F Breiman; Quique Bassat; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Anowar Hossain; Sumon K Das; Martin Antonio; Inacio Mandomando; Tacilta Nhampossa; Sozinho Acácio; Richard Omore; John B Ochieng; Joseph O Oundo; Eric D Mintz; Ciara E O'Reilly; Lynette Y Berkeley; Sofie Livio; Sandra Panchalingam; Dilruba Nasrin; Tamer H Farag; Yukun Wu; Halvor Sommerfelt; Roy M Robins-Browne; Felipe Del Canto; Tracy H Hazen; David A Rasko; Karen L Kotloff; James P Nataro; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2019-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.